Infectious Disease

Top news of the day from across the healthcare landscape.

Technique will help scientists develop an effective HIV vaccine.

Poorer health outcomes found in perinatally HIV-infected youth.

New tuberculosis cases have declined over the past 5 years, but new data show rates are up for TB/HIV coinfections.

Adults who receive vaccination reimbursement through an employer-sponsored pharmacy insurance benefit may be more likely to receive vaccinations, according to data revealed in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition in San Francisco.

Marker helps differentiate dormant HIV-infected cells from their health counterpart cells.

Antibody therapy enables efficacious control of HIV-like virus in monkeys.

Round 2 of study finds a reduction in start time of antiretroviral therapy for HIV treatment.

Treatment with Accolate or Singulair could prevent influenza pneumonia infections.

Insulin could become a new therapeutic option for HIV-associated neurocognitive disorders.

Hypertension can cause cardiovascular risk factors in patients with HIV.

Brain scans could help diagnose patients with HIV-related cognitive issues.

Non-inferiority found between tenofovir disoproxil fumarate and tenofovir alafenamide regimens.

Regimens with Descovy show non-inferiority to those containing Truvada.

Top news of the day from across the health care landscape.

Scientists continue to pursue the development of an HIV cure.

A New Zealand woman who was intentionally infected with HIV and was the center of a high profile criminal case faces down numerous challenges related to the virus.

Scientists utilized nanotechnology to improve HIV treatments.

Top news of the day from across the health care landscape.

Fibroblasts in the gastrointestinal tract help HIV infect immune cells.

Gilead’s antiretroviral medication associated with the increased risk of fracture in patients with HIV.

Statins among promising treatment options helping to progress the HIV treatment landscape.

Novel class of inhibitors may be used as a preventive measure for HIV in the future.

Anxiety and depression linked to longer time living with HIV.

New system could improve the implementation of pre-exposure prophylaxis-based care for HIV prevention.